Skip to content
Press Release
FEATURED | September 11, 2025

Jason Chambers Headlines the Melanoma Research Fou...

Superyacht Captain, TV Personality, Melanoma Patient and Advocate Poised to Emcee Event Honoring the Melanoma Community  New York City, NY (September 11, 2025) – The...

4 Minute Read
Blogs |
May 2, 2022

#GetNaked: Summer

Guest blog post by Summer Sanders, Olympic gold medalist in swimming, American sports commentator, reporter, television personality, actress, cutaneous melanoma survivor an...

4 Minute Read
Blogs |
May 2, 2022

#GetNaked: Monique

Guest blog post by Monique Mack, “In the Sun” documentary participant, melanoma survivor and MRF advocate:   My name is Monique Mack, and I am honored to be a...

3 Minute Read
Press Release |
April 21, 2022

The Melanoma Research Foundation to Host the 2022 ...

ESTERO, FL (April 21, 2022) – The Melanoma Research Foundation (MRF) is thrilled to announce the start of its annual Miles for Melanoma nationwide 5K program bringing...

2 Minute Read
Melanoma News |
April 8, 2022

The MRF Applauds FDA’s Commitment to Propose...

The MRF is proud to join our fellow members of the National Council on Skin Cancer Prevention (NCSCP) in urging the U.S. Food and Drug Administration (FDA) to finalize prop...

1 Minute Read
Blogs |
March 31, 2022

Jamie’s Story: TIL Saved My Life

Guest blog post by Jamie Goldfarb, stage 4 melanoma survivor, clinical trial participant and melanoma advocate: I was diagnosed with stage 4 melanoma in January 2011.  It...

3 Minute Read
Blogs |
March 31, 2022

Patient Perspective: Katie Doble’s Journey w...

Guest blog post by Katie Doble, ocular melanoma (OM) survivor, MRF Courage Award recipient and OM advocate: TIL therapy has given my family and me next-level hope. At 31 ye...

3 Minute Read
Blogs |
March 23, 2022

Recent FDA Approvals for the Melanoma Community

The Melanoma Research Foundation (MRF) is pleased to share recent significant achievements for the melanoma community. In March 2022, the U.S. Food and Drug Administration ...

2 Minute Read
Melanoma News |
March 18, 2022

FDA Grants Investigational New Drug Application fo...

On March 15, the U.S. Food and Drug Administration (FDA) granted Iovance Biotherapeutics, Inc. an Investigational New Drug Application (IND) for IOV-4001, its first geneti...

1 Minute Read
Blogs |
March 4, 2022

MRF Joins 100 Advocacy Organizations in Support of...

On February 25, 2022, the American Cancer Society Cancer Action Network (ACS-CAN) and the National Comprehensive Cancer Network (NCCN) sent a joint letter to the Majority a...

1 Minute Read
Blogs |
February 25, 2022

Rare Disease Day in the MRF Community

As the MRF observes Rare Disease Day on February 28, 2022, we celebrate the courageous and inspiring members of our community who are living with a rare melanoma subtype. M...

3 Minute Read
Blogs |
February 23, 2022

US Representative Carolyn Maloney to Headline MRF ...

WASHINGTON, DC (February 23, 2022) – The Melanoma Research Foundation (MRF) will host nearly 100 advocates during the all-virtual MRF Advocacy Days held March 7-11, 2022....

3 Minute Read
Blogs |
February 22, 2022

Out of the Shadows and “In the Sun”: Reflectio...

Guest blog post by Monique Mack, “In the Sun” documentary participant, melanoma survivor and MRF advocate:   My name is Monique Mack, and I am honored to be an advoca...

3 Minute Read

Oct 25, 2025 ET

CURE OM Global Science Meeting

Oct 30, 2025 ET

24th Annual New York Gala

Oct 30, 2025 ET

Ask The Expert: Minimal Residual Disease Testing in Melanoma Management

Nov 02, 2025 ET

Atlanta Miles for Melanoma 5K

Nov 09, 2025 ET

MRF Brain Metastases Summit 4.0

Nov 13, 2025 ET

DC Wings of Hope Reception

Nov 16, 2025 ET

San Francisco Miles for Melanoma 5K

Explore Events